Skip to main content
MedPathMedPath Home
Clinical Trials/ISRCTN14825568
ISRCTN14825568
Completed
Not Applicable

Ovarian stimulation with follicle stimulating hormone (r-FSH) for women with high early follicular FSH and intra-uterine insemination (IUI) indicatio

VU University Medical Centre (VUMC) (Netherlands)0 sites80 target enrollmentFebruary 14, 2006
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Not specified
Sponsor
VU University Medical Centre (VUMC) (Netherlands)
Enrollment
80
Status
Completed
Last Updated
11 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
February 14, 2006
End Date
TBD
Last Updated
11 years ago
Study Type
Interventional
Sex
Female

Investigators

Sponsor
VU University Medical Centre (VUMC) (Netherlands)

Eligibility Criteria

Inclusion Criteria

  • •1\. Women with elevated early follicular FSH (cycle day 2\-4\)
  • •2\. Women between 18 and 45 years
  • •3\. Regular menstrual cycle between 25 and 35 days
  • •4\. Indication for IUI treatment
  • •5\. Normal hysterosalpingography
  • •6\. Normal serum Ca\-125
  • •7\. Semen analyses: \>2 million progressive motile spermatozoa
  • •8\. Ovulatory cycle

Exclusion Criteria

  • •1\. Untreated other endocrinal pathology
  • •2\. Abnormal vaginal blood loss of unknown origin
  • •3\. Contra\-indications for use of r\-FSH or human choronic gonadotropin (hCG)
  • •4\. Contra\-indications for pregnancy
  • •5\. Congenital uterus anomaly
  • •6\. Endometriosis more than stage II (revised ASRM score)

Outcomes

Primary Outcomes

Not specified

Similar Trials

Completed
Phase 2
FSH effect in OHSS preventioOHSS.Hyperstimulation of ovaries
IRCT201407206063N3Tehran University of Medical Science and Health Service70
Active, not recruiting
Phase 1
uteal phase ovarian stimulation with Follitropin delta and dydrogesteroneVolutary women who wish to donate their oocytesTherapeutic area: Diseases [C] - Female Urogenital Diseases and Pregnancy Complications [C13]
CTIS2024-513998-48-00niversitair Ziekenhuis Brussel50
Active, not recruiting
Phase 1
uteal phase ovarian stimulation with Follitropin delta and dydrogesteroneVolutary women who wish to donate their oocytesTherapeutic area: Diseases [C] - Female diseases of the urinary and reproductive systems and pregancy complications [C13]
EUCTR2022-003049-37-BEZ Brussel50
Active, not recruiting
Phase 1
Initiation of ovarian stimulation in the late follicular phaseSubfertility Oocyte donationMedDRA version: 20.0 Level: LLT Classification code 10042392 Term: Subfertility (female) System Organ Class: 100000004872MedDRA version: 20.0 Level: PT Classification code 10053370 Term: Oocyte donation System Organ Class: 10042613 - Surgical and medical proceduresTherapeutic area: Diseases [C] - Female diseases of the urinary and reproductive systems and pregancy complications [C13]
EUCTR2017-005005-12-BEZ Brussel62
Active, not recruiting
Phase 1
Protocol with Progestin-primed Ovarian Stimulation (PPOS) in conventional treatment from the start of stimulation vs protocol with GnRH antagonists as a pituitary suppressor in patients who are going to undergo DUOSTIM with embryo accumulation for PGT-A of the embryos.
CTIS2023-508769-33-00Ginefiv S.L.144